Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Ocugen Q1 2026 Earnings Call - Gene Therapy Platform Advances with $115M Debt Financing and 2028 BLA Targets
Ocugen’s Q1 2026 results underscore a high-stakes pivot from clinical execution to commercial preparation across its gene therapy platform. The company closed enrollment in two late-stage trials, deli...
- Ocugen announced a $115 million offering of convertible senior notes, extending cash runway into 2028, with potential additional $15 million from warrant exercises.
- The company is advancing a gene-agnostic platform targeting master regulators in retinal diseases, aiming to treat 3 million patients across three late-stage programs.
- Phase III enrollment for OCU400 (retinitis pigmentosa) is complete, with rolling BLA submission expected in Q3 2026 and top-line data in Q1 2027.
- +7 more takeaways
ADM Q1 2026 Earnings Call - RVO Clarity and Ethanol Margins Drive Raised Guidance
ADM delivered a strong first quarter of 2026, driven by a constructive margin environment in ethanol and crushing following the EPA's finalization of Renewable Volume Obligations. The company raised i...
- ADM raised its full-year 2026 adjusted EPS guidance to $4.15-$4.70, up from $3.60-$4.25, citing constructive margin environments and strong execution.
- Q1 2026 adjusted EPS was $0.71, with total segment operating profit of $764 million and a trailing 4-quarter adjusted ROIC of 6.4%.
- The EPA's finalization of 2026 and 2027 Renewable Volume Obligations (RVOs) provided policy clarity, strengthening ethanol margins and soybean crush activity.
- +9 more takeaways
Marriott Vacations Worldwide Q1 2026 Earnings Call - Contract Sales Acceleration Signals Turnaround Inflection Point
Marriott Vacations Worldwide delivered a transitional first quarter, with contract sales down 2% and adjusted EBITDA declining 16% as the company executed on leadership changes, workforce reductions, ...
- Contract sales declined 2% year-over-year to $411 million, with VPG up 1% and tours down 3%, primarily due to planned Asia reductions and lower first-time buyer volume.
- Adjusted EBITDA fell 16% to $161 million, with margin compressing 370 basis points to 19%, reflecting higher marketing costs and product expenses amid transition.
- April contract sales surged 8% year-over-year, powered by an 11% North America lift, signaling that new sales talent and operational changes are gaining traction.
- +7 more takeaways
Integra LifeSciences Q1 2026 Earnings Call - CEO Returns, Guidance Raised, and Commercial Reset
Integra LifeSciences delivered a strong first quarter with revenue of $392 million and adjusted EPS of $0.54, beating the high end of guidance. The company maintained its full-year revenue outlook at ...
- CEO Stuart Essig returns to lead the company, stepping back into the role previously held by Mojdeh Poul, with a focus on commercial execution and culture.
- Full-year adjusted EPS guidance raised to $2.40-$2.50 from prior expectations, driven by tariff benefits and margin improvement.
- Q1 revenue of $392 million beat guidance, with organic growth of 1.3% and strong performance in Tissue Reconstruction.
- +7 more takeaways
UL Solutions Q1 2026 Earnings Call - Margin Expansion and Strategic M&A Drive Outperformance
UL Solutions delivered a standout first quarter in 2026, posting consolidated revenue growth of 7.5% and adjusted EBITDA margin expansion of 320 basis points to 26.0%. The results were driven by disci...
- Consolidated revenue grew 7.5% year-over-year to $758 million, with organic revenue growth of 5.7%, outpacing expectations.
- Adjusted EBITDA surged 22.4% to $197 million, driving a 320 basis point expansion in adjusted EBITDA margin to 26.0%.
- Management raised full-year 2026 adjusted EBITDA margin guidance to approximately 27.0%, up from the previous range, citing strong Q1 performance and restructuring savings.
- +7 more takeaways
ADTRAN Holdings Q1 2026 Earnings Call - Margin Expansion and Data Center Pivot Amid Supply Chain Headwinds
ADTRAN Holdings reported a solid first quarter in 2026, with revenue climbing 15.5% year-over-year to $286.1 million and non-GAAP operating margins expanding 300 basis points to 6.9%. The results were...
- Revenue reached $286.1 million, up 15.5% year-over-year, driven by broad-based strength across optical, access, and subscriber segments.
- Non-GAAP operating margin expanded 300 basis points to 6.9%, marking the highest level since 2020 despite supply chain headwinds.
- Optical Networking Solutions revenue surged 24% year-over-year to $97.3 million, fueled by European vendor displacement and hyperscaler demand.
- +7 more takeaways
Horizon Quantum Q1 2026 Earnings Call - Public Debut with $96.6M Cash, Hardware Testbeds, and Beryllium Language Push
Horizon Quantum has officially entered the public markets following its business combination with dMY Squared Technology Group, listing on Nasdaq and raising $101 million in net financing proceeds. Th...
- Horizon Quantum completed its business combination with dMY Squared Technology Group on March 19, 2026, becoming a public company listed on Nasdaq.
- The company raised $101 million in net financing proceeds, ending the quarter with $96.6 million in cash on the balance sheet.
- Total operating expenses increased to $6.5 million from $4.7 million year-over-year, primarily due to a doubling of the science and engineering headcount.
- +7 more takeaways
Aptiv Q1 2026 Earnings Call - Separation of Versigent Drives Sharper Focus on Software and Non-Automotive Growth
Aptiv delivered Q1 2026 results marked by the successful spin-off of its Electrical Distribution Systems (EDS) business into Versigent, a move designed to sharpen its focus on advanced software and ha...
- Aptiv successfully completed the separation of its Electrical Distribution Systems (EDS) business into a new independent public company, Versigent, allowing the remaining entity to focus on advanced software and optimized hardware solutions.
- Q1 2026 revenue reached $5.1 billion, up 1% year-over-year on an adjusted basis, while adjusted EPS hit a record $1.71, driven by lower interest expense and a reduced share count.
- The company secured $7 billion in new business awards during the quarter, including $900 million from non-automotive customers, underscoring a strategic pivot beyond traditional automotive markets.
- +7 more takeaways
DigitalOcean Q1 2026 Earnings Call - AI-Native Cloud Launch Drives 221% AI ARR Growth
DigitalOcean delivered a record Q1 2026, accelerating revenue growth to 22% year-over-year and raising its full-year 2026 revenue growth guidance to 25-27%. The company’s strategic pivot to an AI-Nati...
- Q1 2026 revenue reached $258 million, up 22% year-over-year, beating the top end of guidance and accelerating from Q4 2025’s 18% growth rate.
- AI customer ARR surged 221% year-over-year to $170 million, with over 80% of that revenue attributed to inference services and core cloud pull-through rather than bare metal.
- Million-dollar customer ARR grew 179% year-over-year to $183 million, reflecting strong expansion among top-tier cloud and AI-native clients.
- +7 more takeaways
Vivid Seats Q1 2026 Earnings Call - App Growth and Private Label Turnaround Drive Sequential Momentum
Vivid Seats reported a strong first quarter 2026, landing at the high end of guidance with sequential growth in gross ticket value (GOV), adjusted EBITDA, and cash. The company’s strategic pivot towar...
- Q1 2026 GOV reached $612 million, up 5.5% sequentially from Q4 2025, defying typical seasonal weakness in the first quarter.
- Consolidated revenue came in at $126 million, essentially flat quarter-over-quarter, with a take rate of 15.9% due to mix shift toward lower-margin private label revenue.
- Adjusted EBITDA surged to $9.5 million from $1 million in Q4 2025, driven by disciplined cost reductions and operating leverage as revenue stabilized.
- +11 more takeaways